Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 10-2023 | 12-2022 | 10-2022 | |
| Operating Expenses | 123,165 | 62,297 | 26,060 | 1,831 | 19,427 |
| Operating Income | -123,165 | -62,297 | -26,060 | -1,831 | -19,427 |
| Interest Expense | 2,994 | 2,798 | 4,953 | 0 | 1,423 |
| Other Income | 8,857 | 9,934 | -68,887 | 1,862 | -3,590 |
| Pre-tax Income | -117,302 | -55,161 | -99,900 | 31 | -24,440 |
| Income Tax | N/A | -19 | 17 | N/A | 22 |
| Net Income Continuous | -117,302 | -55,142 | -99,917 | 31 | -24,462 |
| Net Income | $-117,302 | $-55,142 | $-99,917 | $31 | $-24,462 |
| EPS Basic Total Ops | -2.29 | -1.46 | -151.22 | 0.00 | -44.30 |
| EPS Basic Continuous Ops | -2.29 | -1.46 | -144.18 | 0.01 | -37.34 |
| EPS Diluted Total Ops | -2.29 | -1.46 | -151.22 | 0.00 | -44.30 |
| EPS Diluted Continuous Ops | -2.29 | -1.46 | -144.18 | 0.01 | -37.34 |
| EPS Diluted Before Non-Recurring Items | -2.29 | -1.46 | 151.22 | N/A | N/A |
| EBITDA(a) | $-125,723 | $-62,206 | $-25,885 | $-1,831 | $-19,189 |